Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory Knutson currently holds 29,175,000 shares of U.S. Stem Cell, Inc. (USRM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Knutson has been a net neutral trader of USRM stock. They have purchased $0 and sold $0 worth of shares.
Gregory Knutson's most recent insider trade was on Apr 25, 2022, when they sold 2,500,000 shares at $0.00 per share.
Gregory Knutson serves as Executive at U.S. Stem Cell, Inc. (USRM). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Gregory Knutson holds the position of Executive at U.S. Stem Cell, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Gregory Knutson has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gregory Knutson was on Apr 2, 2021, when they sold $9.4K worth of USRM shares. This transaction involved 187,575 shares at $0.05 per share.
Gregory Knutson currently owns 29,175,000 shares of U.S. Stem Cell, Inc. (USRM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory Knutson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory Knutson has 5 Form 4 filings on record as an insider at U.S. Stem Cell, Inc..
Set alerts for Gregory Knutson and 40,000+ other insiders.